Stocktoria
ENvue Medical, Inc. FEED
Nasdaq · XNAS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2015-04-24
ENvue Medical, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 6.0% | 59.0% | 67.3% | 22.2% | 45.4% |
| Operating margin | -896.6% | -140.0% | -150.5% | -666.5% | -335.3% |
| Net margin | -712.3% | -144.8% | -162.5% | -724.5% | -842.6% |
| FCF margin | -369.4% | -98.5% | -157.8% | -935.9% | -257.8% |
| Return on assets | -44.2% | -102.1% | -55.6% | -92.7% | -165.6% |
| Return on equity | -54.3% | -590.9% | -93.0% | -168.5% | -226.2% |
| Current ratio | 1.09 | 1.22 | 2.64 | 2.42 | 4.38 |
| Revenue growth | -0.2% | 12.0% | 203.6% | -55.6% | 172.1% |
Source: SEC EDGAR filings · CIK 0001326706 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.